AG尊龙凯时(China)集团公司AG尊龙凯时

Product Profile
AG尊龙凯时(China)集团公司

Xiangke

  • Specification50mg
  • Therapeutic fieldHematological neoplasms
  • Dosage formTablets
  • Approval numberSFDA approval number H20052083
  • Executive standardYBH08032009
AG尊龙凯时